Hi,  welcome to EN-CPhI.cn  Sign In Join Free For Buyer

Search Inquiry Cart (0)
Amphaster Nanjin Pharmaceuticals Inc
Amphaster Nanjin Pharmaceuticals Inc
You are here: Home >> Marketing Website>> Company Profile
  • Our Company
  • Year Established: 2009

  • Total Annual Sales(USD): choose not to disclose

  • Total Number of Staff: 200 to 249

  • Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Contract Manufacturing

  • Other Competitive Advantages:

  • Patents and Copyrights:

  • Our Business
  • Business Type: Manufacturer

  • Annual Sales(USD): choose not to disclose

  • Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Major Product Categories: Active Pharmaceutical Ingredients , Bio Products

  • All Products:

  • Product Export Percentage:

  • Product Domestic Sale Percentage:

  • Main Clients' Names:

  • Other Information
  • Contract Manufacturing

  • Payment Terms

Company Profile

Ampharstar(Nanjing) Pharmaceutical Co., Ltd.is the high-tech pharmaceutical company integration of research and development,production,sales,a wholly owned subsidiary invested by Amphastar USA in February 2009. The company currently has  registered capital of $ 61 million with pipeline covering thrombolytic, anti-asthma, Alzheimer's disease and other fields.

Milestones

FDA Inspection

  • From March 30th to April 5th ,2014 , two FDA officials inspected ANP Xinghe Road Site.
  • From April 25th to 29th ,2016 , one FDA official inspected ANP Xinghe Road Site  .

 

 

Last Updated: Jun 11, 2018 Add as my favorite supplier Abuse Report Product Alert
Follow Us
CPhI Online Trade Platform: Worldwide|English|中国站
Customer Service:  86-400 610 1188 (9: 00-18: 00, Mon-Fri)
About Us| Contact Us| Terms of Services| Privacy Policy| Intellectual Property Statement| Links | Site Map
Copyright 2006-20 Shanghai UBM Sinoexpo International Exhibition Co Ltd (All Rights Reserved). ICP 05034851-53
网页对话
live chat